» Articles » PMID: 7520468

Impaired Cytotoxic T Lymphocyte Recognition Due to Genetic Variations in the Main Immunogenic Region of the Human Immunodeficiency Virus 1 NEF Protein

Overview
Journal J Exp Med
Date 1994 Sep 1
PMID 7520468
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus (HIV) induces strong responses from human histocompatibility leukocyte antigen (HLA) class I-restricted cytotoxic T lymphocytes (CTL). In a previous report we identified an immunodominant region (amino acids 73-144) in the NEF protein that was recognized by CD8+ class I-restricted CTL of most asymptomatic individuals. Analysis of the 73-144 region by peptide sensitization, experiments using overlapping peptides corresponding to the LAI isolate identified the peptide sequences located between residues 73 and 82 or 84 and 92 and the peptide sequence between residues 134 and 144 as cognate peptides for HLA-A11- and HLA-B18-restricted epitopes, respectively. This report describes the variable demonstrable reactivities of CTL obtained from HLA-A11 or HLA-B18 seropositive, asymptomatic patients who all had a response to the virus NEF protein, but who did not always recognize appropriate cognate peptides. The high mutation rate of HIV probably facilitates the selection of mutants that can avoid the cellular immune response. We therefore analyzed the variability of these epitopes restricted by HLA-A11 and HLA-B18. We sequenced several viral isolates from HLA-A11 and HLA-B18 donors who recognized certain HLA-peptide complexes and from those who did not. A CTL sensitization assay was used to show that some mutations led to a great reduction in CTL activity in vitro. This might be due to failure of the mutated epitope to bind major histocompatibility complex class I molecule. A simple assay was used to detect peptides that promoted the assembly of class I molecules. Some of these mutations at major anchor positions prevented HLA-A11/peptide binding, and consequently impaired recognition of the HLA-peptide complex by the T cell receptor.

Citing Articles

Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population.

Katoh J, Kawana-Tachikawa A, Shimizu A, Zhu D, Han C, Nakamura H PLoS One. 2016; 11(3):e0150397.

PMID: 26953793 PMC: 4783116. DOI: 10.1371/journal.pone.0150397.


Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1.

Smith K, Mailliard R, Larsen B, Wong K, Gupta P, Mullins J J Virol. 2014; 88(17):9976-90.

PMID: 24942586 PMC: 4136313. DOI: 10.1128/JVI.01275-14.


Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.

Perez C, Milush J, Buggert M, Eriksson E, Larsen M, Liegler T AIDS Res Hum Retroviruses. 2012; 29(3):602-12.

PMID: 23140171 PMC: 3581067. DOI: 10.1089/AID.2012.0171.


Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.

Lewis M, Lee P, Ng H, Yang O J Virol. 2012; 86(13):7126-35.

PMID: 22553319 PMC: 3416312. DOI: 10.1128/JVI.00878-12.


Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.

Cale E, Bazick H, Rianprakaisang T, Alam S, Letvin N J Immunol. 2011; 187(6):3300-13.

PMID: 21841125 PMC: 3175636. DOI: 10.4049/jimmunol.1101080.


References
1.
Teillaud J, Crevat D, Chardon P, Kalil J, Goujet-Zalc C, Mahouy G . Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta 2-microglobulin. Immunogenetics. 1982; 15(4):377-84. DOI: 10.1007/BF00364261. View

2.
Dai L, West K, Littaua R, Takahashi K, Ennis F . Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol. 1992; 66(5):3151-4. PMC: 241078. DOI: 10.1128/JVI.66.5.3151-3154.1992. View

3.
Walker B, Flexner C, Fisher L, Paradis T, Aldovini A, Young R . Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1989; 86(23):9514-8. PMC: 298527. DOI: 10.1073/pnas.86.23.9514. View

4.
Culmann B, Gomard E, Kieny M, Guy B, Dreyfus F, Saimot A . An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immunol. 1989; 19(12):2383-6. DOI: 10.1002/eji.1830191231. View

5.
Martinon F, Gomard E, Hannoun C, LEVY J . In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Eur J Immunol. 1990; 20(10):2171-6. DOI: 10.1002/eji.1830201004. View